These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 27690663
1. Pharmacological treatment of children and adolescents with depression. Vitiello B, Ordóñez AE. Expert Opin Pharmacother; 2016 Dec; 17(17):2273-2279. PubMed ID: 27690663 [Abstract] [Full Text] [Related]
3. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L, Corcos M, Jeammet P. Encephale; 2005 Dec; 31(3):309-16. PubMed ID: 16142045 [Abstract] [Full Text] [Related]
4. Pharmacotherapy of major depressive disorder in adolescents. Masi G, Liboni F, Brovedani P. Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303 [Abstract] [Full Text] [Related]
5. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. Emslie GJ, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS. J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533 [Abstract] [Full Text] [Related]
6. Suicidality in pediatric patients treated with antidepressant drugs. Hammad TA, Laughren T, Racoosin J. Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440 [Abstract] [Full Text] [Related]
7. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. Atkinson SD, Prakash A, Zhang Q, Pangallo BA, Bangs ME, Emslie GJ, March JS. J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026 [Abstract] [Full Text] [Related]
8. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M. Cochrane Database Syst Rev; 2007 Jul 18; (3):CD004851. PubMed ID: 17636776 [Abstract] [Full Text] [Related]
10. Fluoxetine: new indication. Depression in children: too many uncertainties. Prescrire Int; 2008 Oct 18; 17(97):186-7. PubMed ID: 19534039 [No Abstract] [Full Text] [Related]
14. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P. Lancet Psychiatry; 2020 Jul 18; 7(7):581-601. PubMed ID: 32563306 [Abstract] [Full Text] [Related]
15. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J. Arch Gen Psychiatry; 2007 Oct 18; 64(10):1132-43. PubMed ID: 17909125 [Abstract] [Full Text] [Related]
18. Pharmacotherapy in depressed children and adolescents. Taurines R, Gerlach M, Warnke A, Thome J, Wewetzer C. World J Biol Psychiatry; 2011 Sep 18; 12 Suppl 1():11-5. PubMed ID: 21905988 [Abstract] [Full Text] [Related]
19. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Leon AC, Keller MB, Warshaw MG, Mueller TI, Solomon DA, Coryell W, Endicott J. Am J Psychiatry; 1999 Feb 18; 156(2):195-201. PubMed ID: 9989554 [Abstract] [Full Text] [Related]
20. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Lancet; 2016 Aug 27; 388(10047):881-90. PubMed ID: 27289172 [Abstract] [Full Text] [Related] Page: [Next] [New Search]